低剂量重组人脑利钠肽联合多巴胺持续泵入治疗血压偏低的难治性心力衰竭的临床疗效研究被引量：6

在线阅读下载PDF

导出

摘要目的探讨低剂量重组人脑利钠肽(rhBNP)联合多巴胺持续泵入治疗血压偏低的难治性心力衰竭(RHF)患者的临床疗效和安全性。方法 38例血压偏低的RHF患者,采用低剂量rhBNP(不用负荷剂量,只用维持剂量0.0075μg.kg-1.min-1)联合多巴胺持续泵入3～5d,比较患者治疗前后临床症状和体征及心功能情况。结果治疗后较治疗前心率、呼吸频率、氨基末端B型脑钠肽前体(NT-proBNP)降低,血氧饱和度、第一个24h尿量、左室射血分数(LVEF)、左室舒张末内径(LVEDd)增加,差异均有统计学意义(P<0.01);治疗后患者总有效率为94.7%;无明显不良反应发生。结论低剂量rhBNP联合多巴胺不仅可显著改善RHF患者临床症状、体征及心功能,而且安全性好,值得临床推广应用。

作者罗仁茶春喜梁金排

机构地区新疆生产建设兵团第一师医院心血管病科一病区

出处《实用心脑肺血管病杂志》 2013年第9期39-41,共3页 Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease

关键词心力衰竭难治性重组人脑利钠肽多巴胺治疗结果

分类号 R541.6 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献15

1陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2008:775.
2Yaney CW. Treatment with B - type natriuretie peptide for chronic de- compensated heart failure: insights learned from the follow up serial in- fusion of nesiritide (FUSION) trial [J]. Heart Fail Rev, 2004, 9 (3) : 209 -216.
3孙树印,张瑞华,李慧.新活素治疗急性心力衰竭临床观察[J].临床合理用药杂志,2010,3(6):1-2. 被引量：34
4Sudoh T, Kangawa K, Minamino N, et al. A new natriuretic peptide in porcine brain [J]. Nature, 1988, 332:78-81.
5王亮,冷文修,何昆仑,范利.脑钠肽和N末端脑钠肽前体在老年舒张性心力衰竭患者中的比较[J].中华老年心脑血管病杂志,2008,10(6):416-419. 被引量：16
6Chert HH. Heart failure: a state of brain natriurefie peptide deficiency or resistance or both [J]. J Am Coil Cardiol, 2007, 49 (10) : 1089 - 1091.
7Miehaels AD, Klein A, Madden JA, et al. Effects of intravenous ne- siritide on human coronary vasomotor regulation and myocardial oxygen up take [J]. Circulation, 2003, 107:2697-2701.
8Yancy CW,Saltzberg MT,Berkowitz RL,et al. Safety and feasibility of u- sing serial infusions of nesiritide for heart failure in an outpatient setting (from the FUSIONI Trial) [J]. Am J Cardiol,2004,94(5) :595 -601.
9Hiestand B, Abraham WT. Safety and efficacy of nesiritide for acute decompensated heart failure: recent literature and upcoming trials [.l]. Curr Cardiol Rep, 2007, 9: 182-186.
10罗仁,茶春喜.重组人脑利钠肽治疗急性失代偿性心力衰竭的疗效分析[J].新疆医学,2013,43(2):49-52. 被引量：13

二级参考文献56

1毛拥军,张春华,刘松,陈祥鸿.脑钠肽与充血性心力衰竭的治疗[J].中华心血管病杂志,2004,32(9):855-857. 被引量：47
2李世强,傅向华,刘君,谷新顺,张晶,樊欣娜,姜云发,苗青.静脉注射重组人脑利钠肽对急性心肌梗死伴心力衰竭患者的急性血流动力学效应的研究[J].中华心血管病杂志,2006,34(1):23-27. 被引量：102
3谢洪智,朱文玲.重组人脑利钠肽和硝酸甘油治疗急性失代偿性心力衰竭疗效和安全性的随机、开放、平行对照的多中心临床研究[J].中华心血管病杂志,2006,34(3):222-226. 被引量：228
4付尧,杨光,白小涓,贾大林,马玉龙,齐国先.重组人脑利钠肽治疗充血性心力衰竭的疗效评价[J].中国医科大学学报,2006,35(2):191-192. 被引量：35
5Kawakami R,Saito Y,Kishimoto I,et al.Over expression of brain natriuretic peptide facilitates neutrophil infiltration and cardiac matrix metalloproteinase 29 expression after acute myocardial infarction[J].Circulation,2004,110(21):3306-3312.
6Elkayam U,Akhter MW,Singh H,et al.Comparison of effects on left ventricular filling pressure of intravenous nesiritide and high-dose nitroglycerin in patients with decompensated heart failure[J].Am J Cardiol,2004,93(2):237-240.
7Yancy CW,Saltzberg MT,Berkowitz RL,et al.Safety and feasibility of using serial infusions of nesiritide for heart failure in an out patientsetting(from the FUSION I trial)[J].Am J Cardiol,2004,94(5):595-601.
8Witteles RM,Kao D,Christopherson D,et al.Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction a randomized,double-blind,placebo-controlled clinical trial[J].J Am Coll Cardiol,2007,50(19):1835-1840.
9Arora S,Clarke K,Srinivasan V,et al.Effect of nesiritide on renal function in patients admitted for decompensated heart failure[J].QJM,2007,100(11):699-706.
10Cynthuia MB,Pasqualina S,Robert M,et al.Physiological,pathological,phar-macological,biochemical and hematologica factors affecting BNP and NT-pro BNP[J].Clinical Biochemistry,2008,41(4-5):231-239.